Skip to main content
. 2022 Nov 21;33(1):12–21. doi: 10.4103/ijn.ijn_351_21

Table 1.

Demographic and clinical characteristics of cases (n=560)

Percentage (n) Mean±SD Median (range)
Age (years) 32±12.3 30 (12-75)
Males 72.5% (406)
Hypertension 69.8% (391)
SBP (mmHg) 141.3±18.59 140 (100-120)
DBP (mmHg) 85.3±9.7 90 (40-150)
Serum creatinine (mg/dl) 3.08±2.47 2.3 (0.5-17.5)
eGFR (CKD-EPI) (ml/min) 45.9±37.27 34.29 (3.25-160.4)
eGFR less than 60 ml/min 72.5% (406)
24-h urine protein (g) 3.61±2.26 3.24 (0.19-11.42)
Microscopic hematuria (RBC >2/hpf) 63.2% (354)
RBC/hpf 18.5±32.5 8 (0-300)
Proteinuria range
 >3 g/day 46.8% (262)
 1-3 g/day 34.1% (191)
 <1 g/day 19.1% (107)
Syndromic presentation
 Nephrotic syndrome 15.2% (85)
 AKI or AKD 8% (45)
 Recurrent macroscopic hematuria 4.6% (26)
 CKD 54.8% (307)
 ASU 15.5% (87)
 AKI/AKD with macroscopic hematuria 0.3% (2)
 Nephrotic syndrome with macroscopic hematuria 0.5% (3)
 CKD with macroscopic hematuria 0.9% (5)

AKD=acute kidney disease, AKI=acute kidney injury, ASU=asymptomatic urinary abnormality, CKD=chronic kidney disease, CKD-EPI=Chronic Kidney Disease Epidemiology Collaboration, DBP=diastolic blood pressure, RBC=red blood cells, SBP=systolic blood pressure, SD=standard deviation